Explore

Program Map

Start with a treatment, device, company, diagnosis, or trial ID. Each record keeps the source trail close to the claim.

161Main(26 active)

148Status checked

135Strong

320Backlog

More filters and sort (2 active)

Company-led only

1 records in Main database

Compare	Program	Company	Type	Product	Modality	Stage	Status	Reliability	Evidence	Conf.	Population	Indications	Inspect
Add	Neramexane by Merz	Merz Pharmaceuticals GmbH	Therapeutic	-	Small Molecule	Phase 3	Completed	Details checkedClinical trial listing onlyHistorical/discontinued	publication · Priority 2	86%	AdultTinnitus	Tinnitus

Merz Pharmaceuticals GmbH · Small Molecule · Phase 3

CompletedTherapeutic

Evidence

publication

Confidence

86%

Indications

Tinnitus

Population

AdultTinnitus